Times Square Capital Management, LLC Nuvasive Inc Transaction History

Times Square Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 08, 2020	SELL	$32.82 - $81.13 $28.1 Million - $69.4 Million	-855,680 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$60.96 - $77.7 $37.4 Million - $47.7 Million	614,080 Added 254.17%	855,680 $66.2 Million
Q3 2019 Nov 05, 2019	BUY	$55.78 - $68.08 $13.5 Million - $16.4 Million	241,600 New	241,600 $15.3 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Times Square Capital Management, LLC with notifications on news.